Novel transcript, antisense to PDPK1

Novel transcript, antisense to PDPK1 (ENSG00000261613) is classified as an RNA gene, specifically an *antisense RNA* that overlaps the PDPK1 locus in the genome but is transcribed from the opposite strand[5]. There is no publicly available evidence for protein-coding potential, a defined molecular function, or disease associations. It is not considered a therapeutic target (such as a receptor, enzyme, transporter, etc.), nor is there evidence of interacting drugs, mechanistic roles, or biomarker status. The gene is included in databases as an uncharacterized or predicted transcript[5]. Its listing as a target appears to be incorrect unless in a highly specialized context (such as certain transcriptomic studies), and it should not be treated as a canonical drug target.\n\nIn summary, "Novel transcript, antisense to PDPK1" (ENSG00000261613) is a non-coding antisense RNA with no validated target or functional biology related to therapeutics[5].

Other names

ENSG00000261613